Abstracts

DIFFERENTIATED HIV RNA VIRAL-LOAD MONITORING IN UGANDA: A COST-EFFECTIVENESS ANALYSIS

Viral load (VL) monitoring for patients receiving antiretroviral therapy (ART) is recommended worldwide. However, the costs of frequent monitoring are a barrier to implementation in resource-limited settings. The extent to which personalized monitoring frequencies may be cost-effective is unknown. We created a simulation model parameterized using person-level longitudinal data from the Swiss HIV Cohort Study…

A RANDOMIZED TRIAL OF READY-TO-USE SUPPLEMENTARY FOOD AT ART INITIATION IN AFRICA

Early mortality after antiretroviral therapy (ART) initiation is high among HIV-infected adults and children with severe immunosuppression in sub-Saharan Africa. Baseline malnutrition is common and increases mortality, but nutritional supplementation is generally only provided at ART initiation to those with severe malnutrition. Whether universal provision for those with advanced disease would improve nutritional status and…

VIRAL CONTROL INDUCED BY HIVCONSV VACCINES & ROMIDEPSIN IN EARLY TREATED INDIVIDUALS

The combined use of therapeutic vaccination and specific drugs that can reactivate latent reservoir virus (Kick and kill strategies) hold the promise to achieve a functional cure for HIV infection. The recently completed BCN01 vaccine trial (NCT01712425) consisted in a ChAd.HIVconsv and MVA.HIVconsv prime/boost vaccination in early treated individuals (<6 months from HIV acquisition) and…

TELMISARTAN DOES NOT IMPROVE LYMPH NODE OR FAT FIBROSIS IN TREATED HIV INFECTION

Chronic HIV infection is characterized by persistent inflammation and immune activation that can lead to tissue injury and fibrosis. Lymph node (LN) fibrosis may limit CD4+ T-cell recovery; LN and adipose tissue (AT) fibrosis may contribute to systemic inflammation and comorbidities. Telmisartan is an angiotensin receptor blocker and PPAR-γ agonist with anti-inflammatory and anti-fibrotic properties.…

PHARMACOLOGIC INHIBITION OF IDO BLUNTS FEATURES OF SIV-RELATED CHRONIC INFLAMMATION

The immunomodulatory and neurotoxic activities of kynurenines derived from tryptophan catabolism by indoleamine-2,3-dioxygenase (IDO1) play a role in sustaining a cycle of inflammation and immune dysfunction during HIV infection. Such a cycle may lead to increased risks of non-AIDS diseases, such as liver disease and neurocognitive impairment, despite effective cART. We hypothesized that inhibition of…